1AI 16.7% 0.7¢ algorae pharmaceuticals limited

phase II Vs phase I, page-45

  1. 17,045 Posts.
    lightbulb Created with Sketch. 2414
    A low share price limits the possibilities for investment by larger entities because of rules prohibiting inestment in small cap stocks. So if the SP appreciates significantly it widens LCT's appeal.

    I too would like the company to produce a teatment for Huntingtons. Its a horrible fate and if NTcell can alleviate it that would be little short of miraculous for those who have the gene.

    Lets hope the company can find sufficient funds to run trials on all the low hanging fruit as fast as possible.
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.